Subscribe to our Newsletters !!
AMSBIO announce RNAdvantage – the first product
The Metrohm brand stands for highly accurate, robu
As there is not one profile that suits all CPAP pa
Baxter Pharmaceuticals India Pvt. Ltd., today anno
In an effort to bring awareness of the myopia epid
Following the success of the promotion and informa
India's pharmaceuticals industry is a major player
Apomorphine Hydrochloride Hemihydrate (apomorphine) is a morphine decomposition product obtained by boiling the opioid with concentrated acid (the apo- prefix indicates a derivative and the full name means ‘comes from morphine’).
Featured Product: Apomorphine Hydrochloride Hemihydrate API Product Code: MM0562.00 (API)
The pharmalogical and erectogenic properties of its naturally-occurring analogue aporphine were known to the ancient Egyptians and apomorphine has been used for a variety of medical and veterinary purposes since its first synthesis in 1845. These include efforts to employ it as a cure for alcoholism and opioid addiction, while it is also used as an emetic on dogs who have ingested toxins or foreign bodies. In Parkinson’s disease, it is employed as a fast-acting solution to so-called ‘off’ periods, when the effects of regular medication wear off before the next dose is due. Apomorphine is also prescribed in more advanced Parkinson’s cases, when symptoms no longer respond well to first-line drug treatments. It was first approved as a Parkinson’s treatment by the US Food and Drug Administration in 2004, and marketed under brand names including Apokyn, Kynmobi, and Movapo.
Mechanism of action
Parkinson’s disease is a chronic neurodegenerative condition characterised by nerve cells in the brain dying and no longer producing dopamine, which causes problems with movement and other bodily functions. Apomorphine is a type of dopamine D2 agonist, which stimulates nerve cells and helps reduce the symptoms. It is one of a class of organic compounds known as aporphines: quinoline alkaloids containing the dibenzo[de,g]quinoline ring system, or a dehydrogenated derivative thereof. Stimulation of D2 receptors in the caudate-putamen – a region of the brain responsible for locomotor control – may be responsible for apomorphine’s action.
Apomorphine is a type of dopamine D2 agonist, which stimulates nerve cells and helps reduce the symptoms. It is one of a class of organic compounds known as aporphines: quinoline alkaloids containing the dibenzo[de,g]quinoline ring system, or a dehydrogenated derivative thereof.
MM0562.05-0025 Impurity, degradation product Apomorphine o-Quinone (6a,7-Didehydroaporphine-10,11-dione)
MM0562.06-0025 Impurity, degradation product Apomorphine p-Quinone
However, the exact means by which the cellular effects of apomorphine treat hypomobility of Parkinson’s remain unknown.
Working on a different API? You can find all our API and impurity reference materials for antiparkinson drugs here.
For more than 28 years, Mikromol™ reference standards have been produced to the highest quality, to provide you with the reliable quality control and validation materials you need. Today the majority of analytical measurements are performed under our ISO/IEC 17025 scope of accreditation and a leading range of products are manufactured according to our ISO 17034 accreditation.
In our range of more than 6,000 pharmaceutical API, impurity and excipient reference standards, each comes with a comprehensive Certificate of Analysis detailing the characterisation process for the material, and ensuring its suitability for both qualitative and quantitative analysis.